Literature DB >> 29253496

Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).

Aayushi Uberoi1, Satoshi Yoshida1, Paul F Lambert2.   

Abstract

Preclinical model systems to study multiple features of the papillomavirus life cycle are extremely valuable tools to aid our understanding of Human Papillomavirus (HPV) biology, disease progression and treatments. Mouse papillomavirus (MmuPV1) is the first ever rodent papillomavirus that can infect the laboratory strain of mice and was discovered recently in 2011. This model is an attractive model to study papillomavirus pathogenesis due to the ubiquitous availability of lab mice and the fact that this mouse species is easily genetically modifiable. Several other groups, including ours, have reported that MmuPV1-induced papillomas are restricted to T-cell deficient immunosuppressed mice. In our lab we showed for the first time that MmuPV1 causes skin cancers in UVB-irradiated immunocompetent animals. In this report we describe in detail the MmuPV1-UV infection model that can be adapted to study MmuPV1 biology in immunocompetent animals.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immunocompetent; Mouse papillomavirus; Preclinical model; Ultraviolet radiation

Mesh:

Year:  2017        PMID: 29253496      PMCID: PMC5898621          DOI: 10.1016/j.jviromet.2017.12.002

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  54 in total

Review 1.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

2.  Human papillomaviruses are commonly found in normal skin of immunocompetent hosts.

Authors:  G Astori; D Lavergne; C Benton; B Höckmayr; K Egawa; C Garbe; E M de Villiers
Journal:  J Invest Dermatol       Date:  1998-05       Impact factor: 8.551

Review 3.  Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.

Authors:  Kate Connolly; Pete Manders; Peter Earls; Richard J Epstein
Journal:  Cancer Treat Rev       Date:  2013-08-22       Impact factor: 12.111

Review 4.  The biology of beta human papillomaviruses.

Authors:  Massimo Tommasino
Journal:  Virus Res       Date:  2016-11-14       Impact factor: 3.303

5.  Mouse models of human cancer.

Authors:  Barbara C Böck; Ulrike Stein; Clemens A Schmitt; Hellmut G Augustin
Journal:  Cancer Res       Date:  2014-08-18       Impact factor: 12.701

6.  Genomic analysis of the first laboratory-mouse papillomavirus.

Authors:  Joongho Joh; A Bennett Jenson; William King; Mary Proctor; Arvind Ingle; John P Sundberg; Shin-je Ghim
Journal:  J Gen Virol       Date:  2010-11-17       Impact factor: 3.891

7.  Molecular diagnosis of a laboratory mouse papillomavirus (MusPV).

Authors:  Joongho Joh; A Bennett Jenson; Mary Proctor; Arvind Ingle; Kathleen A Silva; Christopher S Potter; John P Sundberg; Shin-je Ghim
Journal:  Exp Mol Pathol       Date:  2012-07-11       Impact factor: 3.362

8.  A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections.

Authors:  Nancy M Cladel; Lynn R Budgeon; Karla K Balogh; Timothy K Cooper; Jiafen Hu; Neil D Christensen
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

9.  Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas.

Authors:  John P Sundberg; Timothy M Stearns; Joongho Joh; Mary Proctor; Arvind Ingle; Kathleen A Silva; Soheil S Dadras; A Bennett Jenson; Shin-je Ghim
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

Review 10.  HPV Carcinomas in Immunocompromised Patients.

Authors:  Nicole M Reusser; Christopher Downing; Jacqueline Guidry; Stephen K Tyring
Journal:  J Clin Med       Date:  2015-01-29       Impact factor: 4.241

View more
  6 in total

1.  A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using Mus musculus Papillomavirus.

Authors:  Renee E King; Andrea Bilger; Josef Rademacher; Ella T Ward-Shaw; Rong Hu; Paul F Lambert; Susan L Thibeault
Journal:  Viruses       Date:  2022-05-08       Impact factor: 5.818

2.  The environmental pollutant and tobacco smoke constituent dibenzo[def,p]chrysene is a co-factor for malignant progression of mouse oral papillomavirus infections.

Authors:  Neil D Christensen; Kun-Ming Chen; Jiafen Hu; Douglas B Stairs; Yuan-Wan Sun; Cesar Aliaga; Karla K Balogh; Hannah Atkins; Debra Shearer; Jingwei Li; Sarah A Brendle; Krishne Gowda; Shantu Amin; Vonn Walter; Raphael Viscidi; Karam El-Bayoumy
Journal:  Chem Biol Interact       Date:  2020-11-10       Impact factor: 5.168

3.  Role of IQGAP1 in Papillomavirus-Associated Head and Neck Tumorigenesis.

Authors:  Tao Wei; Suyong Choi; Darya Buehler; Denis Lee; Ella Ward-Shaw; Richard A Anderson; Paul F Lambert
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.575

4.  An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.

Authors:  Tao Wei; Darya Buehler; Ella Ward-Shaw; Paul F Lambert
Journal:  mBio       Date:  2020-05-12       Impact factor: 7.867

5.  A Novel In Vivo Infection Model To Study Papillomavirus-Mediated Disease of the Female Reproductive Tract.

Authors:  Megan E Spurgeon; Aayushi Uberoi; Stephanie M McGregor; Tao Wei; Ella Ward-Shaw; Paul F Lambert
Journal:  mBio       Date:  2019-03-05       Impact factor: 7.867

6.  A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.

Authors:  Simon Blaine-Sauer; Myeong-Kyun Shin; Kristina A Matkowskyj; Ella Ward-Shaw; Paul F Lambert
Journal:  mBio       Date:  2021-07-20       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.